Tim Doyle Selected Research

Tim Doyle Research Topics

Disease

7	Hyperalgesia 12/2011 - 04/2010
3	Chronic Pain 05/2012 - 11/2010
3	Pain (Aches) 11/2010 - 09/2009
2	Neuralgia (Stump Neuralgia) 05/2012 - 12/2011
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 06/2011 - 01/2008
2	Tuberous Sclerosis (Bourneville's Disease) 06/2011 - 01/2008
1	Seizures (Absence Seizure) 01/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020
1	Bacterial Infections (Bacterial Infection) 11/2014
1	Angiomyolipoma 06/2011
1	Inflammation (Inflammations) 03/2011
1	Hypersensitivity (Allergy) 09/2009
1	Infarction (Infarctions) 09/2009
1	Cicatrix (Scar) 09/2009
1	Ischemia 09/2009
1	Myocardial Infarction 09/2009
1	Infections 02/2008

Drug/Important Bio-Agent (IBA)

4	Analgesics (Analgesic Drugs)IBA 12/2011 - 09/2009
4	CeramidesIBA 08/2011 - 09/2009
3	Peroxynitrous Acid (Peroxynitrite)IBA 12/2011 - 10/2010
3	Morphine (MS Contin)FDA LinkGeneric 11/2010 - 09/2009
2	CarrageenanIBA 12/2011 - 04/2010
2	Sphingosine-1-Phosphate ReceptorsIBA 07/2011 - 03/2011
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 07/2011 - 03/2011
2	Sirolimus (Rapamycin)FDA Link 06/2011 - 01/2008
2	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2011 - 10/2010
2	acetovanillone (apocynin)IBA 03/2011 - 10/2010
2	Opiate AlkaloidsIBA 11/2010 - 09/2009
2	Superoxide DismutaseIBA 10/2010 - 04/2010
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2020
1	Urea (Carbamide)FDA LinkGeneric 11/2014
1	DNA Topoisomerase IV (Topoisomerase IV)IBA 11/2014
1	taxaneIBA 05/2012
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 05/2012
1	Bortezomib (Velcade)FDA Link 05/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2012
1	PlatinumIBA 05/2012
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 05/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2012
1	Proteasome InhibitorsIBA 05/2012
1	manganese(III) porphyrinIBA 12/2011
1	SB 203580IBA 08/2011
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 08/2011
1	SC 514IBA 08/2011
1	Phosphotransferases (Kinase)IBA 08/2011
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2011
1	ProstaglandinsIBA 08/2011
1	Prostaglandins EIBA 08/2011
1	SphingolipidsIBA 08/2011
1	Dinoprostone (PGE2)FDA Link 08/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2011
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2011
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2011
1	lipoarabinomannan (LAM)IBA 06/2011
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 03/2011
1	Superoxides (Superoxide)IBA 10/2010
1	NitrogenIBA 10/2010
1	diphenyleneiodoniumIBA 10/2010
1	Oxygen (Dioxygen)IBA 10/2010
1	PorphyrinsIBA 04/2010
1	Dizocilpine Maleate (Dizocilpine)IBA 04/2010
1	EnzymesIBA 04/2010
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2010
1	1-methylpyridiniumIBA 04/2010
1	Proteins (Proteins, Gene)FDA Link 09/2009
1	CytokinesIBA 09/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2009
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2008

Therapy/Procedure

2	Therapeutics 06/2011 - 01/2008
1	Oral Administration 12/2011
1	Pain Management 03/2011